Oncology Molecular Diagnostics Market 2022: New Trends, Drivers and RestraintsPosted by Biswadeep on March 21st, 2022 Oncology Molecular Diagnostics Global Market Report 2022 by The Business Research Company is the most comprehensive report available on the market, being wide-ranging both in terms of chronology and geography. It covers the historic period – 2016-2021, and the forecast period – 2022-2026, with additional forecasts for 2026-2031. The report helps gain a truly global perspective as it covers 60 geographies, focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. TBRC’s market report includes a chapter on the COVID-19 impact on the oncology molecular diagnostics industry, which gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market and how companies can strategize to bounce back from it. With updated market numbers according to the effects of the coronavirus, the report provides the most accurate expected oncology molecular diagnostics market growth numbers from 2022-2031. Request a Sample of the report: The global oncology molecular diagnostics market size is expected to grow from .22 billion in 2021 to .66 billion in 2022 at a compound annual growth rate (CAGR) of 13.6%. The global oncology molecular diagnostic market size is expected to grow to .34 billion in 2026 at a CAGR of 14.7%. View more on the report: The Oncology Molecular Diagnostics Global Market Report 2022-31 by The Business Research Company evaluates oncology molecular diagnostics market size, growth rate, drivers, oncology molecular diagnostics industry trends, and major companies. The oncology molecular diagnostics market segments in the report are: 1) By Product: Instruments, Reagents, Others 2) By Technology: Polymerase Chain Reaction (PCR), In-Situ Hybridization (ISH), Isothermic Nucleic Acid Amplification Technology (INAAT), Chips and Microarrays, Sequencing, Mass Spectroscopy, Transcription Mediated Amplification (TMA), Others 3) By End-User: Hospitals, Diagnostic Centers, Academic and Research Institutes, Others The table of contents in TBRC’s oncology molecular diagnostics market report includes:
About The Business Research Company:
Contact Information: Like it? Share it!More by this author |